Clinical Trial Details
| Trial ID: | L3440 |
| Source ID: | NCT02288273 |
| Associated Drug: | Bydureon |
| Title: | Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes. |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT02288273/results |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Bydureon|DRUG: Placebo |
| Outcome Measures: | Primary: Change in 24-hour Mean Weighted Glucose, Change in 24-hour mean weighted glucose from baseline (Day -1/1) to Day 6 of Week 4 (Day 27/28) and to Day 6 of Week 10 (Day 69/70)., Day 27/28 | Secondary: Change in 24-hour Mean Weighted Glucose Between Day 1 of Week 10 (Day 64/65) and Day 6 of Week 10 (Day 69/70) Within Each EQW-treated Patient, Day 64/65|Change From Baseline (Day1) to Day 70 and Day 22 in FPG, Day 22/Day70|Change From Baseline (Day -1) to Day 64 and Day 22 in 2- Hour Mean Weighted PPG (After the Breakfast Meal), Day 22 and Day 64|Average of Change in 24-hour Mean Weighted Glucose From Baseline to Week 4 and Baseline to Week 10, Week 4 and Week 10|Change in HbA1c From Baseline to Day 22 and Baseline to Day 70, Day 22 and Day 70 |
| Sponsor/Collaborators: | Sponsor: AstraZeneca |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 239 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2014-12 |
| Completion Date: | 2015-08 |
| Results First Posted: | 2017-01-27 |
| Last Update Posted: | 2017-01-27 |
| Locations: | Research Site, Anaheim, California, United States|Research Site, Chino, California, United States|Research Site, Los Angeles, California, United States|Research Site, North Hollywood, California, United States|Research Site, Santa Ana, California, United States|Research Site, Spring Valley, California, United States|Research Site, Tustin, California, United States|Research Site, Walnut Creek, California, United States|Research Site, Hollywood, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Port Orange, Florida, United States|Research Site, Marietta, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Edina, Minnesota, United States|Research Site, St Louis, Missouri, United States|Research Site, Butte, Montana, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Franklin, Ohio, United States|Research Site, Marion, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Mt Pleasant, South Carolina, United States|Research Site, Rapid City, South Dakota, United States|Research Site, Corpus Christi, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Katy, Texas, United States|Research Site, Salt Lake City, Utah, United States|Research Site, Burke, Virginia, United States|Research Site, Manassas, Virginia, United States|Research Site, Olympia, Washington, United States |
| URL: | https://clinicaltrials.gov/show/NCT02288273 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|